Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer: final analysis of overall survival.

Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer: final analysis of overall survival / Francini E; Fiaschi AI; Petrioli R; Bianco V; Laera L; Francini F; Roviello G. - In: ANTI-CANCER DRUGS. - ISSN 0959-4973. - STAMPA. - (2015), pp. 472-477. [10.1097/CAD.0000000000000072]

Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer: final analysis of overall survival

Francini E;Roviello G
2015

Abstract

Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer: final analysis of overall survival.
2015
472
477
Goal 3: Good health and well-being for people
Francini E; Fiaschi AI; Petrioli R; Bianco V; Laera L; Francini F; Roviello G
1a - Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1156807
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 7
social impact